Lv51
1410 积分 2022-06-14 加入
MDM2 inhibitors in sarcomas: results and next steps
1个月前
已完结
Clear cell mesotheliomas with inactivating VHL mutations and near‐haploid genomic features
1个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
2个月前
已完结
AACR-NCI-EORTC - 33rd International Symposium on Molecular Targets and Cancer Therapeutics. Virtual - October 7-10, 2021
2个月前
已完结
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
5个月前
已完结
Structure-Based Design of New LSD1/EGFRL858R/T790M Dual Inhibitors for Treating EGFR Mutant NSCLC Cancers
5个月前
已完结
A Comprehensive Review of Targeting RAF Kinase in Cancer Targeting RAF Kinase in Cancer
8个月前
已完结
Epidermal growth factor receptor mutations in breast Cancer: Therapeutic challenges and way forward
8个月前
已完结
Sunvozertinib monotherapy in EGFR tyrosine kinase Inhibitor-Resistant Non-Small cell lung cancer with EGFR mutations
8个月前
已完结
Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis
8个月前
已完结
皖公网安备34019202002308
